Global CRISPR And CRISPR-Associated (Cas) Genes Market Research Report 2021 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2027
ReportID: 543199
|
Published Date: 11/08/2021
|
No. of Pages: 137
|
Categories: Life Sciences
|
Format : 
The global CRISPR And CRISPR-Associated (Cas) Genes market was valued at 36.4 Million USD in 2020 and will grow with a CAGR of 38.64% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea. CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45.70% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes. Although this market has great potential for future development, we do not recommend entering the market for investors who do not have strong capital or do not have key technology.
By Market Verdors:
Caribou Biosciences
Addgene
CRISPR THERAPEUTICS
Merck KGaA
Mirus Bio LLC
Editas Medicine
Takara Bio USA
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
GE Healthcare Dharmacon
By Types:
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
By Applications:
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea. CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45.70% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes. Although this market has great potential for future development, we do not recommend entering the market for investors who do not have strong capital or do not have key technology.
By Market Verdors:
Caribou Biosciences
Addgene
CRISPR THERAPEUTICS
Merck KGaA
Mirus Bio LLC
Editas Medicine
Takara Bio USA
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
GE Healthcare Dharmacon
By Types:
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
By Applications:
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by CRISPR And CRISPR-Associated (Cas) Genes Revenue
1.4 Market Analysis by Type
1.4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Genome Editing
1.4.3 Genetic engineering
1.4.4 gRNA Database/Gene Librar
1.4.5 CRISPR Plasmid
1.4.6 Human Stem Cells
1.4.7 Genetically Modified Organisms/Crops
1.4.8 Cell Line Engineering
1.5 Market by Application
1.5.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Share by Application: 2022-2027
1.5.2 Biotechnology Companies
1.5.3 Pharmaceutical Companies
1.5.4 Academic Institutes
1.5.5 Research and Development Institutes
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global CRISPR And CRISPR-Associated (Cas) Genes Market
1.8.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Manufacturers (2016-2021)
2.3 Global CRISPR And CRISPR-Associated (Cas) Genes Average Price by Manufacturers (2016-2021)
2.4 Manufacturers CRISPR And CRISPR-Associated (Cas) Genes Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Market Share by Region (2016-2021)
3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Revenue Market Share by Region (2016-2021)
3.3 North America CRISPR And CRISPR-Associated (Cas) Genes Sales Volume
3.3.1 North America CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.3.2 North America CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume
3.4.1 East Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales Volume (2016-2021)
3.5.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.5.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume (2016-2021)
3.6.1 South Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume (2016-2021)
3.7.1 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East CRISPR And CRISPR-Associated (Cas) Genes Sales Volume (2016-2021)
3.8.1 Middle East CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa CRISPR And CRISPR-Associated (Cas) Genes Sales Volume (2016-2021)
3.9.1 Africa CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.9.2 Africa CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania CRISPR And CRISPR-Associated (Cas) Genes Sales Volume (2016-2021)
3.10.1 Oceania CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America CRISPR And CRISPR-Associated (Cas) Genes Sales Volume (2016-2021)
3.11.1 South America CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.11.2 South America CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World CRISPR And CRISPR-Associated (Cas) Genes Sales Volume (2016-2021)
3.12.1 Rest of the World CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Market Share by Type (2016-2021)
14.2 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Revenue Market Share by Type (2016-2021)
14.3 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Volume by Application (2016-2021)
15.2 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in CRISPR And CRISPR-Associated (Cas) Genes Business
16.1 Caribou Biosciences
16.1.1 Caribou Biosciences Company Profile
16.1.2 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.1.3 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Addgene
16.2.1 Addgene Company Profile
16.2.2 Addgene CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.2.3 Addgene CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 CRISPR THERAPEUTICS
16.3.1 CRISPR THERAPEUTICS Company Profile
16.3.2 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.3.3 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Merck KGaA
16.4.1 Merck KGaA Company Profile
16.4.2 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.4.3 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Mirus Bio LLC
16.5.1 Mirus Bio LLC Company Profile
16.5.2 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.5.3 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Editas Medicine
16.6.1 Editas Medicine Company Profile
16.6.2 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.6.3 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Takara Bio USA
16.7.1 Takara Bio USA Company Profile
16.7.2 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.7.3 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Thermo Fisher Scientific
16.8.1 Thermo Fisher Scientific Company Profile
16.8.2 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.8.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Horizon Discovery Group
16.9.1 Horizon Discovery Group Company Profile
16.9.2 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.9.3 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Intellia Therapeutics
16.10.1 Intellia Therapeutics Company Profile
16.10.2 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.10.3 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 GE Healthcare Dharmacon
16.11.1 GE Healthcare Dharmacon Company Profile
16.11.2 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.11.3 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Cost Analysis
17.1 CRISPR And CRISPR-Associated (Cas) Genes Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of CRISPR And CRISPR-Associated (Cas) Genes
17.4 CRISPR And CRISPR-Associated (Cas) Genes Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 CRISPR And CRISPR-Associated (Cas) Genes Distributors List
18.3 CRISPR And CRISPR-Associated (Cas) Genes Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of CRISPR And CRISPR-Associated (Cas) Genes (2022-2027)
20.2 Global Forecasted Revenue of CRISPR And CRISPR-Associated (Cas) Genes (2022-2027)
20.3 Global Forecasted Price of CRISPR And CRISPR-Associated (Cas) Genes (2016-2027)
20.4 Global Forecasted Production of CRISPR And CRISPR-Associated (Cas) Genes by Region (2022-2027)
20.4.1 North America CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.2 East Asia CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.4 South Asia CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.6 Middle East CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.7 Africa CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.8 Oceania CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.9 South America CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
21.2 East Asia Market Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
21.3 Europe Market Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Countriy
21.4 South Asia Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
21.5 Southeast Asia Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
21.6 Middle East Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
21.7 Africa Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
21.8 Oceania Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
21.9 South America Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
21.10 Rest of the world Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by CRISPR And CRISPR-Associated (Cas) Genes Revenue
1.4 Market Analysis by Type
1.4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Genome Editing
1.4.3 Genetic engineering
1.4.4 gRNA Database/Gene Librar
1.4.5 CRISPR Plasmid
1.4.6 Human Stem Cells
1.4.7 Genetically Modified Organisms/Crops
1.4.8 Cell Line Engineering
1.5 Market by Application
1.5.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Share by Application: 2022-2027
1.5.2 Biotechnology Companies
1.5.3 Pharmaceutical Companies
1.5.4 Academic Institutes
1.5.5 Research and Development Institutes
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global CRISPR And CRISPR-Associated (Cas) Genes Market
1.8.1 Global CRISPR And CRISPR-Associated (Cas) Genes Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Manufacturers (2016-2021)
2.3 Global CRISPR And CRISPR-Associated (Cas) Genes Average Price by Manufacturers (2016-2021)
2.4 Manufacturers CRISPR And CRISPR-Associated (Cas) Genes Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Market Share by Region (2016-2021)
3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Revenue Market Share by Region (2016-2021)
3.3 North America CRISPR And CRISPR-Associated (Cas) Genes Sales Volume
3.3.1 North America CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.3.2 North America CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume
3.4.1 East Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales Volume (2016-2021)
3.5.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.5.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume (2016-2021)
3.6.1 South Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume (2016-2021)
3.7.1 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East CRISPR And CRISPR-Associated (Cas) Genes Sales Volume (2016-2021)
3.8.1 Middle East CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa CRISPR And CRISPR-Associated (Cas) Genes Sales Volume (2016-2021)
3.9.1 Africa CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.9.2 Africa CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania CRISPR And CRISPR-Associated (Cas) Genes Sales Volume (2016-2021)
3.10.1 Oceania CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America CRISPR And CRISPR-Associated (Cas) Genes Sales Volume (2016-2021)
3.11.1 South America CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.11.2 South America CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World CRISPR And CRISPR-Associated (Cas) Genes Sales Volume (2016-2021)
3.12.1 Rest of the World CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Volume Market Share by Type (2016-2021)
14.2 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Revenue Market Share by Type (2016-2021)
14.3 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Volume by Application (2016-2021)
15.2 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in CRISPR And CRISPR-Associated (Cas) Genes Business
16.1 Caribou Biosciences
16.1.1 Caribou Biosciences Company Profile
16.1.2 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.1.3 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Addgene
16.2.1 Addgene Company Profile
16.2.2 Addgene CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.2.3 Addgene CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 CRISPR THERAPEUTICS
16.3.1 CRISPR THERAPEUTICS Company Profile
16.3.2 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.3.3 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Merck KGaA
16.4.1 Merck KGaA Company Profile
16.4.2 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.4.3 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Mirus Bio LLC
16.5.1 Mirus Bio LLC Company Profile
16.5.2 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.5.3 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Editas Medicine
16.6.1 Editas Medicine Company Profile
16.6.2 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.6.3 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Takara Bio USA
16.7.1 Takara Bio USA Company Profile
16.7.2 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.7.3 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Thermo Fisher Scientific
16.8.1 Thermo Fisher Scientific Company Profile
16.8.2 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.8.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Horizon Discovery Group
16.9.1 Horizon Discovery Group Company Profile
16.9.2 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.9.3 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Intellia Therapeutics
16.10.1 Intellia Therapeutics Company Profile
16.10.2 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.10.3 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 GE Healthcare Dharmacon
16.11.1 GE Healthcare Dharmacon Company Profile
16.11.2 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Product Specification
16.11.3 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Cost Analysis
17.1 CRISPR And CRISPR-Associated (Cas) Genes Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of CRISPR And CRISPR-Associated (Cas) Genes
17.4 CRISPR And CRISPR-Associated (Cas) Genes Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 CRISPR And CRISPR-Associated (Cas) Genes Distributors List
18.3 CRISPR And CRISPR-Associated (Cas) Genes Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of CRISPR And CRISPR-Associated (Cas) Genes (2022-2027)
20.2 Global Forecasted Revenue of CRISPR And CRISPR-Associated (Cas) Genes (2022-2027)
20.3 Global Forecasted Price of CRISPR And CRISPR-Associated (Cas) Genes (2016-2027)
20.4 Global Forecasted Production of CRISPR And CRISPR-Associated (Cas) Genes by Region (2022-2027)
20.4.1 North America CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.2 East Asia CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.4 South Asia CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.6 Middle East CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.7 Africa CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.8 Oceania CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.9 South America CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World CRISPR And CRISPR-Associated (Cas) Genes Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
21.2 East Asia Market Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
21.3 Europe Market Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Countriy
21.4 South Asia Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
21.5 Southeast Asia Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
21.6 Middle East Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
21.7 Africa Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
21.8 Oceania Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
21.9 South America Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
21.10 Rest of the world Forecasted Consumption of CRISPR And CRISPR-Associated (Cas) Genes by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
Published On:11/08/2021
Base Year:
Historical Data:
No of Pages:137
Price
Global CRISPR And CRISPR-Associated (Cas) Genes Market Research Report 2021 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2027
A2Z Market Research is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.
Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
